The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner
Open accessAbstract
Histone modifications reflect gene activity, but the relationship between cause and consequence of transcriptional control is heavily debated. Recent developments in rewriting local histone codes of endogenous genes elucidated instructiveness of certain marks in regulating gene expression. Maintenance of such repressive epigenome editing is controversial, while stable reactivation is still largely unexplored. Here we demonstrate sustained gene re-expression using two types of engineered DNA-binding domains fused to a H3K4 methyltransferase. Local induction of H3K4me3 is sufficient to allow re-expression of silenced target genes in various cell types. Maintenance of the re-expression is achieved, but strongly depends on the chromatin microenvironment (that is, DNA methylation status). We further identify H3K79me to be essential in allowing stable gene re-expression, confirming its role in epigenetic crosstalk for stable reactivation. Our approach uncovers potent epigenetic modifications to be directly written onto genomic loci to stably activate any given gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“…to target each promoter based on previous reports indicating that multiple gRNAs at a single promoter are more effective for gene activation 15,16,18,19,21,22 . dCas9-VP64 was able to induce EpCAM gene expression in both cell lines, whereas gRNA-directed dCas-PRDM9 and dCas-VP64 were…”
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 1×
“…to target each promoter based on previous reports indicating that multiple gRNAs at a single promoter are more effective for gene activation 15,16,18,19,21,22 . dCas9-VP64 was able to induce EpCAM gene expression in both cell lines, whereas gRNA-directed dCas-PRDM9 and dCas-VP64 were ineffective…”
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
Hilton, I. B., D'Ippolito, A. M., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3199 · Cited by 1,885
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
Perez-Pinera, P., Kocak, D. D., Vockley, C. M., Adler, A. F., Kabadi, A. M., Polstein, L. R., Thakore, P. I., Glass, K. A., Ousterout, D. G., Leong, K. W., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2600 · Cited by 1,328
CRISPR RNA–guided activation of endogenous human genes
Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H., & Joung, J. K. (2013) · Nature Methods · doi:10.1038/nmeth.2598 · Cited by 1,249
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147
Shilatifard, A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142422 · Cited by 1,103
PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice
Baudat, F., Buard, J., Grey, C., Fledel-Alon, A., Ober, C., Przeworski, M., Coop, G., & de Massy, B. (2010) · Science · doi:10.1126/science.1183439 · Cited by 1,026
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944
Optical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2013) · Nature · doi:10.1038/nature12466 · Cited by 803
Schübeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., Delrow, J., et al. (2004) · Genes & Development · doi:10.1101/gad.1198204 · Cited by 796
Cheng, A. W., Wang, H., Yang, H., Shi, L., Katz, Y., Theunissen, T. W., Rangarajan, S., Shivalila, C. S., Dadon, D. B., & Jaenisch, R. (2013) · Cell Research · doi:10.1038/cr.2013.122 · Cited by 751
Maeder, M. L., Angstman, J. F., Richardson, M. E., Linder, S. J., Cascio, V. M., Tsai, S. Q., Ho, Q. H., Sander, J. D., Reyon, D., Bernstein, B. E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2726 · Cited by 501
Histone modification: cause or cog?
Henikoff, S., & Shilatifard, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.06.006 · Cited by 482
H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation
Lauberth, S. M., Nakayama, T., Wu, X., Ferris, A. L., Tang, Z., Hughes, S. H., & Roeder, R. G. (2013) · Cell · doi:10.1016/j.cell.2013.01.052 · Cited by 473
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
Kelly, T. K., Liu, Y., Lay, F. D., Liang, G., Berman, B. P., & Jones, P. A. (2012) · Genome Research · doi:10.1101/gr.143008.112 · Cited by 455
Nucleosomes impede Cas9 access to DNA in vivo and in vitro
Horlbeck, M. A., Witkowsky, L. B., Guglielmi, B., Replogle, J. M., Gilbert, L. A., Villalta, J. E., Torigoe, S. E., Tjian, R., & Weissman, J. S. (2016) · eLife · doi:10.7554/elife.12677 · Cited by 415
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Szyf, M. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103102 · Cited by 374
Locus-specific editing of histone modifications at endogenous enhancers
Mendenhall, E. M., Williamson, K. E., Reyon, D., Zou, J. Y., Ram, O., Joung, J. K., & Bernstein, B. E. (2013) · Nature Biotechnology · doi:10.1038/nbt.2701 · Cited by 366
Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/Cas
Farzadfard, F., Perli, S. D., & Lu, T. K. (2013) · ACS Synthetic Biology · doi:10.1021/sb400081r · Cited by 358
Ram, O., Goren, A., Amit, I., Shoresh, N., Yosef, N., Ernst, J., Kellis, M., Gymrek, M., Issner, R., Coyne, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.057 · Cited by 331
Histone modifications: signalling receptors and potential elements of a heritable epigenetic code
Nightingale, K. P., O’Neill, L. P., & Turner, B. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.02.015 · Cited by 311
Kearns, N. A., Genga, R. M. J., Enuameh, M. S., Garber, M., Wolfe, S. A., & Maehr, R. (2014) · Development · doi:10.1242/dev.103341 · Cited by 294
Modeling gene expression using chromatin features in various cellular contexts
Dong, X., Greven, M. C., Kundaje, A., Djebali, S., Brown, J. B., Cheng, C., Gingeras, T. R., Gerstein, M., Guigó, R., Birney, E., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r53 · Cited by 256
Langbecker, D., & Janda, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00001 · Cited by 228
Epigenetic reprogramming of cancer cells via targeted DNA methylation
Rivenbark, A. G., Stolzenburg, S., Beltran, A. S., Yuan, X., Rots, M. G., Strahl, B. D., & Blancafort, P. (2012) · Epigenetics · doi:10.4161/epi.19507 · Cited by 223
Self-citationRobust, synergistic regulation of human gene expression using TALE activators
Maeder, M. L., Linder, S. J., Reyon, D., Angstman, J. F., Fu, Y., Sander, J. D., & Joung, J. K. (2013) · Nature Methods · doi:10.1038/nmeth.2366 · Cited by 182
de Groote, M. L., Verschure, P. J., & Rots, M. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks863 · Cited by 180
Self-citationInduced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter
Chen, H., Kazemier, H. G., de Groote, M. L., Ruiters, M. H. J., Xu, G.-L., & Rots, M. G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1019 · Cited by 166
Self-citationTargeted silencing of the oncogenic transcription factor SOX2 in breast cancer
Stolzenburg, S., Rots, M. G., Beltran, A. S., Rivenbark, A. G., Yuan, X., Qian, H., Strahl, B. D., & Blancafort, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks360 · Cited by 165
Self-citationCharacterization of human epigenomes
Wang, Z., Schones, D. E., & Zhao, K. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.02.001 · Cited by 160
Structural Insight into the Recognition of the H3K4me3 Mark by the TFIID Subunit TAF3
van Ingen, H., van Schaik, F. M. A., Wienk, H., Ballering, J., Rehmann, H., Dechesne, A. C., Kruijzer, J. A. W., Liskamp, R. M. J., Timmers, H. T. M., & Boelens, R. (2008) · Structure · doi:10.1016/j.str.2008.04.015 · Cited by 155
The n-SET Domain of Set1 Regulates H2B Ubiquitylation-Dependent H3K4 Methylation
Kim, J., Kim, J., McGinty, R. K., Nguyen, U. T. T., Muir, T. W., Allis, C. D., & Roeder, R. G. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.034 · Cited by 151
Using Targeted Chromatin Regulators to Engineer Combinatorial and Spatial Transcriptional Regulation
Keung, A. J., Bashor, C. J., Kiriakov, S., Collins, J. J., & Khalil, A. S. (2014) · Cell · doi:10.1016/j.cell.2014.04.047 · Cited by 145
Molecular Basis for the Regulation of the H3K4 Methyltransferase Activity of PRDM9
Wu, H. Y., Mathioudakis, N., Diagouraga, B., Dong, A., Dombrovski, L., Baudat, F., Cusack, S., de Massy, B., & Kadlec, J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.035 · Cited by 126
Stolzenburg, S., Beltrán, A. S., Swift‐Scanlan, T., Rivenbark, A. G., Rashwan, R., & Blancafort, P. (2015) · Oncogene · doi:10.1038/onc.2014.470 · Cited by 99
Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained
Kungulovski, G., Nunna, S., Thomas, M., Zanger, U. M., Reinhardt, R., & Jeltsch, A. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0002-z · Cited by 95
Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing
Falahi, F., Huisman, C., Kazemier, H. G., van der Vlies, P., Kok, K., Hospers, G. A. P., & Rots, M. G. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0567 · Cited by 76
Self-citationThe adjustable nucleosome: an epigenetic signaling module
Turner, B. M. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.04.003 · Cited by 75
Synthetic epigenetics—towards intelligent control of epigenetic states and cell identity
Jurkowski, T. P., Ravichandran, M., & Stepper, P. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0044-x · Cited by 74
Epigenome Engineering in Cancer: Fairytale or a Realistic Path to the Clinic?
Falahi, F., Sgro, A., & Blancafort, P. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00022 · Cited by 72
Beltrán, A. S., Sun, X., Lizardi, P. M., & Blancafort, P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0526 · Cited by 63
Magnenat, L., Blancafort, P., & Barbas, C. F. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.030 · Cited by 57
Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor
Beltrán, A. S., Russo, A., Lara, H., Fan, C., Lizardi, P. M., & Blancafort, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024595 · Cited by 55
Li, K., Pang, J., Cheng, H., Liu, W., Di, J., Xiao, H.-J., Luo, Y., Zhang, H., Huang, W., Chen, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3192 · Cited by 53
Meisetz, A Novel Histone Tri-Methyltransferase, Regulates Meiosis-Specific Epigenesis
Hayashi, K., & Matsui, Y. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2572 · Cited by 49
Gregory, D. J., Zhang, Y., Kobzik, L., & Fedulov, A. V. (2013) · Epigenetics · doi:10.4161/epi.26267 · Cited by 46
Huisman, C., Wisman, G. B. A., Kazemier, H. G., van Vugt, M. A. T. M., van der Zee, A. G. J., Schuuring, E. M. D., & Rots, M. G. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.017 · Cited by 43
Self-citationRusk, N. (2013) · Nature Methods · doi:10.1038/nmeth.2775 · Cited by 37
Huisman, C., van der Wijst, M. G. P., Falahi, F., Overkamp, J., Karsten, G., Terpstra, M. M., Kok, K., van der Zee, A. G., Schuuring, E. M. D., Wisman, G. B. A., et al. (2015) · Epigenetics · doi:10.1080/15592294.2015.1034415 · Cited by 33
Self-citationHistone Crosstalk: H2Bub and H3K4 Methylation
Soares, L. M. M., & Buratowski, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.012 · Cited by 31
Jacinto, F. V., Ballestar, E., & Esteller, M. (2009) · Oncogene · doi:10.1038/onc.2009.267 · Cited by 31
Voigt, P., & Reinberg, D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2756 · Cited by 27
Brave new epigenomes: the dawn of epigenetic engineering
Köferle, A., Stricker, S. H., & Beck, S. (2015) · Genome Medicine · doi:10.1186/s13073-015-0185-8 · Cited by 23
Cited by
The CRISPR tool kit for genome editing and beyond
Adli, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04252-2 · Cited by 1,545
Histone post-translational modifications - cause and consequence of genome function
Millán-Zambrano, G., Burton, A., Bannister, A. J., & Schneider, R. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00468-7 · Cited by 1,116
Is H3K4me3 instructive for transcription activation?
Howe, F. S., Fischl, H., Murray, S. C., & Mellor, J. (2017) · BioEssays · doi:10.1002/bies.201600095 · Cited by 513
Clinical epigenetics: seizing opportunities for translation
Berdasco, M., & Esteller, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0074-2 · Cited by 498
CRISPR technologies for precise epigenome editing
Nakamura, M., Gao, Y., Dominguez, A. A., & Qi, L. S. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00620-7 · Cited by 444
Metadata
- Authors
- Cano-Rodriguez, D., Gjaltema, R. A. F., Jilderda, L. J., Jellema, P., Dokter-Fokkens, J., Ruiters, M. H. J., & Rots, M. G.
- Venue
- Nature Communications
- Published
- 2016-08-10
- Volume
- 7
- Issue
- 1
- Pages
- 12284-12284
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2501443726
- Cited by
- 275
- References
- 60
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.